Scinai Immunotherapeutics
$0.64
17
+$0.07+12.12% Wednesday 20:00
Statistics
Day High
0.71
Day Low
0.58
52W High
6.18
52W Low
0.55
Volume
673,244
Avg. Volume
42,019
Mkt Cap
0
P/E Ratio
0.35
Dividend Yield
-
Dividend
-
Financials
728.88%Profit Margin
Profitable1.32MRevenue
9.59MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SCNI. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Show more...
CEO
Mr. Amir Reichman M.B.A., M.Sc.
Employees
31
Country
IL
ISIN
US09073Q3039
Listings
0 Comments
Share your thoughts
FAQ
What is Scinai Immunotherapeutics stock price today?▼
The current price of SCNI is $0.64 USD — it has increased by +12.12% in the past 24 hours. Watch Scinai Immunotherapeutics stock price performance more closely on the chart.
What is Scinai Immunotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Scinai Immunotherapeutics stocks are traded under the ticker SCNI.
Is Scinai Immunotherapeutics stock price growing?▼
SCNI stock has risen by +6.34% compared to the previous week, the month change is a -24.82% fall, over the last year Scinai Immunotherapeutics has showed a -77.58% decrease.
What is Scinai Immunotherapeutics revenue for the last year?▼
Scinai Immunotherapeutics revenue for the last year amounts to 1.32M USD.
What is Scinai Immunotherapeutics net income for the last year?▼
SCNI net income for the last year is 9.59M USD.
How many employees does Scinai Immunotherapeutics have?▼
As of April 02, 2026, the company has 31 employees.
In which sector is Scinai Immunotherapeutics located?▼
Scinai Immunotherapeutics operates in the Information Technology sector.
When did Scinai Immunotherapeutics complete a stock split?▼
The last stock split for Scinai Immunotherapeutics was on May 21, 2024 with a ratio of 1:10.
Where is Scinai Immunotherapeutics headquartered?▼
Scinai Immunotherapeutics is headquartered in Jerusalem, IL.